Articles You Might Have Missed Taylor SandersD. Lynne McKeeE. Mason Jackson Articles you might have missed Open access 04 June 2024
American College of Medical Toxicology Research Agenda 2024—2030 Neeraj ChhabraAlison MeynPaul Wax Special Article 04 June 2024
Correction: Safety of Physostigmine for Pediatric Antimuscarinic Poisoning Sarah HuberRobert AveraKristine Nañagas Correction 28 May 2024
In Response to “Comment on Ensuring the Efficacy and Safety of Approved Medications” Maryann Mazer-AmirshahiJon B. ColeLewis S. Nelson The Poison Pen 03 May 2024
Comment on “Ensuring the Efficacy and Safety of Approved Medications ” J. OppenheimerThomas B. CasaleSarina Tanimoto The Poison Pen Open access 02 May 2024
Do Asymptomatic Patients Need Endoscopy after Caustic Ingestion? James D. WhitledgeMichele M. Burns Editorial 29 April 2024
Is EGD Needed in all Patients after Suicidal or Exploratory Caustic Ingestions? Michael LevineYaron FinkelsteinStephen H. Thomas Original Article 22 April 2024
ACMT Comment on Recent Guidance on PFAS Laboratory Testing John W. DownsNicholas E. NaccaMichael G. Holland Position Statement 18 April 2024
Appreciation and Gratitude to Journal of Medical Toxicology (JMT) Peer Reviewers in 2023 Howard A. GrellerMark B. Mycyk Acknowledgements 12 March 2024 Pages: 248 - 249
2024 ACMT Annual Scientific Meeting Abstracts – Washington, DC Annual Meeting Abstracts 08 March 2024 Pages: 86 - 192
Navigating a Startup Journey: The Journal of Medical Toxicology Christian Tomaszewski Editorial 06 March 2024 Pages: 77 - 78
Smartphone and Wearable Device-Based Digital Phenotyping to Understand Substance use and its Syndemics Jasper S. LeeEmma BrowningPeter R. Chai Preliminary Research 04 March 2024 Pages: 205 - 214
The Voice of Medical Toxicology: Celebrating 20 Years of the Journal of Medical Toxicology Anthony F. PizonLouise KaoPaul M. Wax Editorial 04 March 2024 Pages: 79 - 80
Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017–2022 Christopher E. GawHannah L. HaysGary A. Smith Original Article Open access 29 February 2024 Pages: 193 - 204
Welcome to the 2024 ACMT Annual Scientific Meeting Michael ToceCharlotte E. GoldfineAlison Meyn Editorial 26 February 2024 Pages: 84 - 85
Ensuring the Efficacy and Safety of Approved Medications Maryann Mazer-AmirshahiJon B. ColeLewis S. Nelson Editorial 23 February 2024 Pages: 81 - 83
Articles You Might Have Missed Rafael LimaShawn Luo Articles you might have missed 20 February 2024 Pages: 245 - 247
Case Files of the Emory University Medical Toxicology Fellowship: A Patient Presents to the Outpatient Toxicology Clinic with Delusions of Being Poisoned Matthew Robert DernbachJoseph E. Carpenter Case Files 20 February 2024 Pages: 233 - 244
ACMT Clinicopathological Conference: The Intoxicated, Poisoned Groundskeeper Antonia NemanichMichael Keenan Special Article 20 February 2024 Pages: 226 - 232
Use of Registries and Large Databases for Toxicology Research Maryann Mazer-AmirshahiDaniel A. LaubMark B. Mycyk Special Article 16 February 2024
Toxicity Following Tranexamic Acid Overdose James ChenowethStacy MarshallTimothy Albertson Research Letter 09 February 2024 Pages: 215 - 217
Food Poisoning by Oleander Skewers: Investigation of a Toxicologic Urban Legend Jeffrey R. SuchardJerald LimKenneth Schmitt Special Article 07 February 2024 Pages: 222 - 225
Safety of Physostigmine for Pediatric Antimuscarinic Poisoning Sarah HuberRobert AveraKristine Nañagas Original Article 24 January 2024
QT-Interval Prolongation Associated with Supratherapeutic Guanfacine Concentration: A Case Report Fumiya InoueYuji OkazakiAkira Namera Case Report 17 January 2024 Pages: 218 - 221
Women and Authorship in Medical Toxicology: Canaries in the Coal Mine Natalie R. NeumannGillian A. Beauchamp Editorial 03 January 2024 Pages: 7 - 9
Correction: American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time Andrew I. StolbachMaryann Mazer‑AmirshahiJon B. Cole Correction 28 December 2023 Pages: 75 - 75
20 Years of JMT: Trying to Catch a Heffalump Kevin C. Osterhoudt Editorial 22 December 2023 Pages: 3 - 6
Fentanyl Exposure and Detection Strategies Utilized by Clinical Trial Participants Seeking Linkage to Opioid Use Disorder Treatment at a Syringe Service Program Dennis P. WatsonBradley RayNicole Gastala Original Article Open access 04 December 2023 Pages: 13 - 21
Response to Comment on: “Methylene Blue–Induced Serotonin Toxicity: Case Files of the Medical Toxicology Fellowship at the New York City Poison Control Center” Corey HazekampZach SchmitzAnthony Scoccimarro The Poison Pen 30 November 2023 Pages: 70 - 71
American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time Andrew I. StolbachMaryann Mazer-AmirshahiJon B. Cole Position Statement 30 November 2023 Pages: 64 - 67
A Decade in Review: Trends in Female Authorship in Peer-Reviewed Toxicology Journals Jennifer S. LoveGeorge T. LooAyrn D. O’Connor Original Article 30 November 2023 Pages: 22 - 30
Articles You Might Have Missed Joseph EbersoleMatthew DernbachMayank Gupta Articles you might have missed 27 November 2023 Pages: 59 - 63
The Poison Pen: A Primer to Writing Letters to the Editor Paul F. EhlersLewis S. Nelson Editorial 27 November 2023 Pages: 10 - 12
Comment on: “Methylene Blue-Induced Serotonin Toxicity: Case Files of the Medical Toxicology Fellowship at the New York City Poison Control Center” Erin RyanFrank Paloucek The Poison Pen 22 November 2023 Pages: 68 - 69
Commercial Delta-8 THC Products: an Analysis of Content and Labeling Eric E. KaczorKevin GreeneStephanie P. Carreiro Original Article 02 November 2023 Pages: 31 - 38
Investigation of Cerebral Mitochondrial Injury in a Porcine Survivor Model of Carbon Monoxide Poisoning Constantine D. MavroudisAlistair LewisDavid H. Jang Preliminary Research 17 October 2023 Pages: 39 - 48
A Case of Severe Lead Encephalopathy with Cardiac Arrest Managed During a Chelation Shortage Damilola IdowuZachary GrayDavid Gummin Case Report 16 October 2023 Pages: 49 - 53
Methylene Blue–Induced Serotonin Toxicity: Case Files of the Medical Toxicology Fellowship at the New York City Poison Control Center Corey HazekampZach SchmitzAnthony Scoccimarro Case Files 12 October 2023 Pages: 54 - 58
Response to Comment on “Induction of Labor at Term for Severe Antenatal Lead Poisoning” Sanjay MohanChristian KoziatekMark K. Su The Poison Pen 10 October 2023 Pages: 74 - 74
Comment on “Induction of Labor at Term for Severe Antenatal Lead Poisoning” Priyanka PradhanDhara P. AminJoanne C. Routsolias The Poison Pen 06 October 2023 Pages: 72 - 73
Accuracy of a Glycerol Dehydrogenase Assay for Ethylene Glycol Detection Ari B. FilipChristopher W. FarnsworthJeffrey A. Kraut Original Article 11 September 2023 Pages: 362 - 367
Chronic Doxepin Toxicity Masquerading as Epilepsy in a 10-Year-Old Boy James D. WhitledgeC. James WatsonMichele M. Burns Case Report 08 September 2023 Pages: 405 - 410
Assessing Platelet Mitochondrial Dysfunction in a Murine Model of Acute Acetaminophen Toxicity Carolyn FoxMichael L. EkaneyChristine M. Murphy Original Article 29 August 2023 Pages: 341 - 351
The Toxicology Investigators Consortium 2022 Annual Report Alexandra M. AmaducciSharan L. CamplemanOn behalf of the Toxicology Investigators Consortium Study Group Original Article 29 August 2023 Pages: 313 - 340
Factors Affecting the Choice to Specialize in Medical Toxicology Michael KeenanNicholas TitelbaumEmily Kiernan Original Article 28 August 2023 Pages: 389 - 397
Toxicity and Adverse Effects in Clozapine-Related Presentations to a Medical Toxicology Service in Western Sydney Pramod ChandruNaren Gunja Original Article 25 August 2023 Pages: 374 - 380
Adverse Events in Pregnant Patients Treated with Coronavirus Disease 2019 Therapeutics Mark SimonJennie BuchananOn behalf of the Toxicology Investigators Consortium FACT Study Group Original Article 15 August 2023 Pages: 381 - 388
ACMT Position Statement: Position on the Recent Judicial Challenge of U.S. Food and Drug Administration Approval of Mifepristone Maryann Mazer-AmirshahiAndrew I. StolbachPeggy Ye Position Statement 07 August 2023 Pages: 414 - 415